Previous Article | Next Article 
Journal of Virology, June 2003, p. 6419-6429, Vol. 77, No. 11
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.11.6419-6429.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading
Makoto Inoue,1* Yumiko Tokusumi,1 Hiroshi Ban,1 Takumi Kanaya,1 Masayuki Shirakura,1 Tsuyoshi Tokusumi,1 Takahiro Hirata,1 Yoshiyuki Nagai,2 Akihiro Iida,1 and Mamoru Hasegawa1
DNAVEC Research Inc., Tsukuba-shi, Ibaraki 305-0856,1
Toyama Institute of Health, Kosugi-machi, Imizu-gun, Toyama 939-0363, Japan2
Received 29 October 2002/
Accepted 13 February 2003
A new recombinant Sendai virus vector (SeV/
M), in which the gene encoding matrix (M) protein was deleted, was recovered from cDNA and propagated in a packaging cell line expressing M protein by using a Cre/loxP induction system. The titer of SeV/
M carrying the enhanced green fluorescent protein gene in place of the M gene was 7 x 107 cell infectious units/ml or more. The new vector showed high levels of infectivity and gene expression, similar to those of wild-type SeV vector, in vitro and in vivo. Virus maturation into a particle was almost completely abolished in cells infected with SeV/
M. Instead, SeV/
M infection brought about a significant increase of syncytium formation under conditions in which the fusion protein was proteolytically cleaved and activated by trypsin-like protease. This shows that SeV/
M spreads markedly to neighboring cells in a cell-to-cell manner, because both hemagglutinin-neuraminidase and active fusion proteins are present at very high levels on the surface of cells infected with SeV/
M. Thus, SeV/
M is a novel type of vector with the characteristic features of loss of virus particle formation and gain of cell-to-cell spreading via a mechanism dependent on the activation of the fusion protein.
* Corresponding author. Mailing address: 1-25-11 Kannondai, Tsukuba-shi, Ibaraki 305-0856, Japan. Phone: 81-29-838-0540. Fax: 81-29-839-1123. E-mail: inoue{at}dnavec.co.jp.
Journal of Virology, June 2003, p. 6419-6429, Vol. 77, No. 11
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.11.6419-6429.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Nakao, I., Kanaji, S., Ohta, S., Matsushita, H., Arima, K., Yuyama, N., Yamaya, M., Nakayama, K., Kubo, H., Watanabe, M., Sagara, H., Sugiyama, K., Tanaka, H., Toda, S., Hayashi, H., Inoue, H., Hoshino, T., Shiraki, A., Inoue, M., Suzuki, K., Aizawa, H., Okinami, S., Nagai, H., Hasegawa, M., Fukuda, T., Green, E. D., Izuhara, K.
(2008). Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease. J. Immunol.
180: 6262-6269
[Abstract]
[Full Text]
-
Mottet-Osman, G., Iseni, F., Pelet, T., Wiznerowicz, M., Garcin, D., Roux, L.
(2007). Suppression of the Sendai Virus M Protein through a Novel Short Interfering RNA Approach Inhibits Viral Particle Production but Does Not Affect Viral RNA Synthesis. J. Virol.
81: 2861-2868
[Abstract]
[Full Text]
-
Pantua, H. D., McGinnes, L. W., Peeples, M. E., Morrison, T. G.
(2006). Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles. J. Virol.
80: 11062-11073
[Abstract]
[Full Text]
-
Armeanu, S., Bitzer, M., Smirnow, I., Bossow, S., Appel, S., Ungerechts, G., Bernloehr, C., Neubert, W. J., Lauer, U. M., Brossart, P.
(2005). Severe Impairment of Dendritic Cell Allostimulatory Activity by Sendai Virus Vectors Is Overcome by Matrix Protein Gene Deletion. J. Immunol.
175: 4971-4980
[Abstract]
[Full Text]
-
Sakaguchi, T., Kato, A., Sugahara, F., Shimazu, Y., Inoue, M., Kiyotani, K., Nagai, Y., Yoshida, T.
(2005). AIP1/Alix Is a Binding Partner of Sendai Virus C Protein and Facilitates Virus Budding. J. Virol.
79: 8933-8941
[Abstract]
[Full Text]
-
Iwadate, Y., Inoue, M., Saegusa, T., Tokusumi, Y., Kinoh, H., Hasegawa, M., Tagawa, M., Yamaura, A., Shimada, H.
(2005). Recombinant Sendai Virus Vector Induces Complete Remission of Established Brain Tumors through Efficient Interleukin-2 Gene Transfer in Vaccinated Rats. Clin. Cancer Res.
11: 3821-3827
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.